DK3299356T3 - Fremgangsmåde til fremstilling af pleuromutiliner - Google Patents

Fremgangsmåde til fremstilling af pleuromutiliner Download PDF

Info

Publication number
DK3299356T3
DK3299356T3 DK17197350.6T DK17197350T DK3299356T3 DK 3299356 T3 DK3299356 T3 DK 3299356T3 DK 17197350 T DK17197350 T DK 17197350T DK 3299356 T3 DK3299356 T3 DK 3299356T3
Authority
DK
Denmark
Prior art keywords
pleuromutilins
preparation
Prior art date
Application number
DK17197350.6T
Other languages
English (en)
Inventor
Rosemarie Riedl
Lee Spence
Werner Heilmayer
Original Assignee
Nabriva Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics GmbH filed Critical Nabriva Therapeutics GmbH
Application granted granted Critical
Publication of DK3299356T3 publication Critical patent/DK3299356T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17197350.6T 2010-05-26 2011-05-23 Fremgangsmåde til fremstilling af pleuromutiliner DK3299356T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20100450092 EP2399904A1 (en) 2010-05-26 2010-05-26 Process for the preparation of pleuromutilins
EP11724938.3A EP2576505B1 (en) 2010-05-26 2011-05-23 Crystalline form of a pleuromutilin

Publications (1)

Publication Number Publication Date
DK3299356T3 true DK3299356T3 (da) 2022-01-31

Family

ID=42937801

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17197350.6T DK3299356T3 (da) 2010-05-26 2011-05-23 Fremgangsmåde til fremstilling af pleuromutiliner
DK11724938.3T DK2576505T3 (da) 2010-05-26 2011-05-23 Krystallinsk form af en pleuromutilin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11724938.3T DK2576505T3 (da) 2010-05-26 2011-05-23 Krystallinsk form af en pleuromutilin

Country Status (29)

Country Link
US (1) US9120727B2 (da)
EP (3) EP2399904A1 (da)
JP (2) JP6038021B2 (da)
KR (1) KR101935333B1 (da)
CN (2) CN105111117A (da)
AU (1) AU2011257938B2 (da)
BR (1) BR112012029982A2 (da)
CA (1) CA2799029C (da)
DK (2) DK3299356T3 (da)
EA (1) EA023273B1 (da)
ES (2) ES2659729T3 (da)
HR (1) HRP20220201T1 (da)
HU (2) HUE035861T2 (da)
IL (1) IL222999A (da)
MA (1) MA34332B1 (da)
MX (1) MX347176B (da)
MY (1) MY164666A (da)
NZ (1) NZ603804A (da)
PH (1) PH12012502321A1 (da)
PL (2) PL3299356T3 (da)
PT (2) PT2576505T (da)
SG (1) SG185104A1 (da)
SI (1) SI3299356T1 (da)
TN (1) TN2012000506A1 (da)
TR (1) TR201802636T4 (da)
TW (1) TWI585073B (da)
UA (1) UA108378C2 (da)
WO (1) WO2011146954A1 (da)
ZA (1) ZA201208056B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法
SI3310331T1 (sl) * 2015-06-17 2021-02-26 Nabriva Therapeutics GmbH Farmacevtska formulacija lefamulina, ki se jo da injicirati
US20160367567A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
UA123099C2 (uk) 2015-06-18 2021-02-17 Естетра Спрл Диспергована в порожнині рота одиниця дозування, яка містить естетрольний компонент
TWI762573B (zh) * 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN107417586A (zh) * 2017-06-21 2017-12-01 华南农业大学 一种截短侧耳素类抗生素及其制备方法和应用
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI755055B (zh) * 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN111170893B (zh) * 2020-01-19 2022-04-26 郑州依米花手性药物研究有限公司 Lefamulin的中间体化合物及其在Lefamulin制备中的应用
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US20230218558A1 (en) 2020-04-17 2023-07-13 Nabriva Therapeutics GmbH Novel therapeutic use of pleuromutilins
IL297268A (en) * 2020-04-17 2022-12-01 Nabriva Therapeutics GmbH Therapeutic use of pleuromutilins
WO2023152115A1 (en) 2022-02-09 2023-08-17 Nabriva Therapeutics GmbH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia
CN118894800A (zh) * 2024-06-27 2024-11-05 福建省微生物研究所 一种Lefamulin中间体化合物的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207370A (ja) * 1985-03-11 1986-09-13 Seitetsu Kagaku Co Ltd 4−(メタンスルホニルオキシ)チオフエノ−ルの製法
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
EP1534678B1 (en) * 2002-07-24 2007-10-31 Nabriva Therapeutics Forschungs GmbH Pleuromutilin derivatives as antimicrobbials
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
HRP20080192T3 (hr) * 2003-08-04 2008-05-31 "Joint Stock Company Grindeks" Meldonijeve soli, postupci za njihovu pripravu i farmaceutski sastav na njihovoj osnovi
JP5144930B2 (ja) * 2003-08-18 2013-02-13 ハー・ルンドベック・アクチエゼルスカベット トランス−1−(6−クロロ−3−フェニルインダン−1−イル)−3,3−ジメチルピペラジン
ATE450535T1 (de) * 2003-09-03 2009-12-15 Glaxo Group Ltd Neues verfahren zur herstellung von pleuromutilinderivaten
US9697672B2 (en) 2006-07-20 2017-07-04 Bally Gaming, Inc. Wagering game with special-event eligibility feature based on passive game play
EP1908750A1 (en) * 2006-10-05 2008-04-09 Nabriva Therapeutics Forschungs GmbH Process for the preparation of pleuromutilins
PT1961735E (pt) * 2007-02-22 2009-12-21 Indena Spa Processo para a preparação de sal de acetato de éster metílico de (2r,3s)-3-fenilisoserina
EP1972618A1 (en) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
EP2159220A1 (en) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds

Also Published As

Publication number Publication date
ES2659729T3 (es) 2018-03-19
PL3299356T3 (pl) 2022-04-04
SG185104A1 (en) 2012-12-28
CA2799029A1 (en) 2011-12-01
HRP20220201T1 (hr) 2022-04-29
PH12012502321A1 (en) 2013-02-11
ES2909198T3 (es) 2022-05-05
IL222999A (en) 2016-02-29
HK1253006A1 (en) 2019-06-06
CN103080083A (zh) 2013-05-01
CA2799029C (en) 2019-01-29
JP6501742B2 (ja) 2019-04-17
EP3299356B1 (en) 2021-11-24
TWI585073B (zh) 2017-06-01
PL2576505T3 (pl) 2018-05-30
EA201291370A1 (ru) 2013-09-30
HUE057587T2 (hu) 2022-05-28
WO2011146954A1 (en) 2011-12-01
EP3299356A1 (en) 2018-03-28
HUE035861T2 (hu) 2018-06-28
TW201209026A (en) 2012-03-01
IL222999A0 (en) 2013-02-03
CN105111117A (zh) 2015-12-02
JP2016210804A (ja) 2016-12-15
NZ603804A (en) 2014-03-28
CN103080083B (zh) 2016-03-02
MX347176B (es) 2017-04-17
MY164666A (en) 2018-01-30
JP6038021B2 (ja) 2016-12-07
PT2576505T (pt) 2018-03-05
US20130079400A1 (en) 2013-03-28
BR112012029982A2 (pt) 2020-09-01
DK2576505T3 (da) 2018-03-05
EP2576505A1 (en) 2013-04-10
TN2012000506A1 (en) 2014-04-01
AU2011257938B2 (en) 2016-06-23
US9120727B2 (en) 2015-09-01
PT3299356T (pt) 2022-02-21
ZA201208056B (en) 2014-01-29
MX2012013645A (es) 2013-05-01
KR101935333B1 (ko) 2019-01-04
EP2399904A1 (en) 2011-12-28
JP2013528162A (ja) 2013-07-08
TR201802636T4 (tr) 2018-03-21
EA023273B1 (ru) 2016-05-31
EP2576505B1 (en) 2017-11-29
MA34332B1 (fr) 2013-06-01
SI3299356T1 (sl) 2022-05-31
UA108378C2 (uk) 2015-04-27
KR20130079406A (ko) 2013-07-10

Similar Documents

Publication Publication Date Title
DK3299356T3 (da) Fremgangsmåde til fremstilling af pleuromutiliner
SMT201600271B (it) BENZOSSAZEPINONI FUSI COME MODULATORI DI CANALl IONICI
DK2718404T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrider
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
HUE056588T2 (hu) Eljárás poliolefinek elõállítására
DK2736837T3 (da) Fremgangsmåde til fremstilling af nanosiliciumtråde
DK3178851T3 (da) Anti-cd40-antistoffer
SMT201600464B (it) Procedimento per la preparazione di esterolo
DK2386683T3 (da) Fremgangsmåde til fremstilling af gel-baserede kompositmaterialer
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
DK2718403T3 (da) Fremgangsmåde til fremstilling af flydende carbonhydrid
DK2635282T3 (da) Sammensætninger til behandling af myelofibrose
DK2768796T3 (da) Fremgangsmåde til fremstilling af quinolin-derivater
CO6960555A2 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
DK2593449T3 (da) Fremgangsmåde til syntese af benzothiadiazolforbindelse
CO6910197A2 (es) Compuestos novedosos
DK2526425T3 (da) Fremgangsmåde til diagnosticering af endometriel receptivitet
DK2595948T3 (da) Fremgangsmåde til fremstilling af ingenol-3-angelat
BR112013025299A2 (pt) conjunto de ancoragem
DK2836460T3 (da) Fremgangsmåde til fremstilling af graphen
DK3444238T3 (da) Fremgangsmåde til fremstilling af difluormethylenforbindelser
DK2728009T3 (da) Fremgangsmåde til fremstilling af monosaccharider
DK2627656T3 (da) Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf
EP2768515A4 (en) GLUCOSYLSTEVIA COMPOSITION
DK2598479T3 (da) Fremgangsmåde til fremstilling af Ramipril